Cargando…

Report on the National Eye Institute Audacious Goals Initiative: Replacement of Retinal Ganglion Cells from Endogenous Cell Sources

This report emerges from a workshop convened by the National Eye Institute (NEI) as part of the “Audacious Goals Initiative” (AGI). The workshop addressed the replacement of retinal ganglion cells (RGCs) from exogenous and endogenous sources, and sought to identify the gaps in our knowledge and barr...

Descripción completa

Detalles Bibliográficos
Autores principales: Vetter, Monica L., Hitchcock, Peter F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354473/
https://www.ncbi.nlm.nih.gov/pubmed/28316878
http://dx.doi.org/10.1167/tvst.6.2.5
_version_ 1782515322606059520
author Vetter, Monica L.
Hitchcock, Peter F.
author_facet Vetter, Monica L.
Hitchcock, Peter F.
author_sort Vetter, Monica L.
collection PubMed
description This report emerges from a workshop convened by the National Eye Institute (NEI) as part of the “Audacious Goals Initiative” (AGI). The workshop addressed the replacement of retinal ganglion cells (RGCs) from exogenous and endogenous sources, and sought to identify the gaps in our knowledge and barriers to progress in devising cellular replacement therapies for diseases where RGCs die. Here, we briefly review relevant literature regarding common diseases associated with RGC death, the genesis of RGCs in vivo, strategies for generating transplantable RGCs in vitro, and potential endogenous cellular sources to regenerate these cells. These topics provided the clinical and scientific context for the discussion among the workshop participants and are relevant to efforts that may lead to therapeutic approaches for replacing RGCs. This report also summarizes the content of the workshop discussion, which focused on: (1) cell sources for RGC replacement and regeneration, (2) optimizing integration, survival, and synaptogenesis of new RGCs, and (3) approaches for assessing the outcomes of RGC replacement therapies. We conclude this report with a summary of recommendations, based on the workshop discussions, which may guide vision scientists seeking to develop therapies for replacing RGCs in humans.
format Online
Article
Text
id pubmed-5354473
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher The Association for Research in Vision and Ophthalmology
record_format MEDLINE/PubMed
spelling pubmed-53544732017-03-19 Report on the National Eye Institute Audacious Goals Initiative: Replacement of Retinal Ganglion Cells from Endogenous Cell Sources Vetter, Monica L. Hitchcock, Peter F. Transl Vis Sci Technol New Developments in Vision Research This report emerges from a workshop convened by the National Eye Institute (NEI) as part of the “Audacious Goals Initiative” (AGI). The workshop addressed the replacement of retinal ganglion cells (RGCs) from exogenous and endogenous sources, and sought to identify the gaps in our knowledge and barriers to progress in devising cellular replacement therapies for diseases where RGCs die. Here, we briefly review relevant literature regarding common diseases associated with RGC death, the genesis of RGCs in vivo, strategies for generating transplantable RGCs in vitro, and potential endogenous cellular sources to regenerate these cells. These topics provided the clinical and scientific context for the discussion among the workshop participants and are relevant to efforts that may lead to therapeutic approaches for replacing RGCs. This report also summarizes the content of the workshop discussion, which focused on: (1) cell sources for RGC replacement and regeneration, (2) optimizing integration, survival, and synaptogenesis of new RGCs, and (3) approaches for assessing the outcomes of RGC replacement therapies. We conclude this report with a summary of recommendations, based on the workshop discussions, which may guide vision scientists seeking to develop therapies for replacing RGCs in humans. The Association for Research in Vision and Ophthalmology 2017-03-15 /pmc/articles/PMC5354473/ /pubmed/28316878 http://dx.doi.org/10.1167/tvst.6.2.5 Text en Copyright 2017 The Authors http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License.
spellingShingle New Developments in Vision Research
Vetter, Monica L.
Hitchcock, Peter F.
Report on the National Eye Institute Audacious Goals Initiative: Replacement of Retinal Ganglion Cells from Endogenous Cell Sources
title Report on the National Eye Institute Audacious Goals Initiative: Replacement of Retinal Ganglion Cells from Endogenous Cell Sources
title_full Report on the National Eye Institute Audacious Goals Initiative: Replacement of Retinal Ganglion Cells from Endogenous Cell Sources
title_fullStr Report on the National Eye Institute Audacious Goals Initiative: Replacement of Retinal Ganglion Cells from Endogenous Cell Sources
title_full_unstemmed Report on the National Eye Institute Audacious Goals Initiative: Replacement of Retinal Ganglion Cells from Endogenous Cell Sources
title_short Report on the National Eye Institute Audacious Goals Initiative: Replacement of Retinal Ganglion Cells from Endogenous Cell Sources
title_sort report on the national eye institute audacious goals initiative: replacement of retinal ganglion cells from endogenous cell sources
topic New Developments in Vision Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354473/
https://www.ncbi.nlm.nih.gov/pubmed/28316878
http://dx.doi.org/10.1167/tvst.6.2.5
work_keys_str_mv AT vettermonical reportonthenationaleyeinstituteaudaciousgoalsinitiativereplacementofretinalganglioncellsfromendogenouscellsources
AT hitchcockpeterf reportonthenationaleyeinstituteaudaciousgoalsinitiativereplacementofretinalganglioncellsfromendogenouscellsources
AT reportonthenationaleyeinstituteaudaciousgoalsinitiativereplacementofretinalganglioncellsfromendogenouscellsources